TW200801191A - Activating agent of stem cells and/or progenitor cells - Google Patents

Activating agent of stem cells and/or progenitor cells

Info

Publication number
TW200801191A
TW200801191A TW095136179A TW95136179A TW200801191A TW 200801191 A TW200801191 A TW 200801191A TW 095136179 A TW095136179 A TW 095136179A TW 95136179 A TW95136179 A TW 95136179A TW 200801191 A TW200801191 A TW 200801191A
Authority
TW
Taiwan
Prior art keywords
cells
activating agent
thrombin
progenitor
enzyme
Prior art date
Application number
TW095136179A
Other languages
Chinese (zh)
Other versions
TWI382090B (en
Inventor
Hirobumi Senga
Zhongchao Han
Dingfang Cai
Li Li
Original Assignee
Tobishi Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tobishi Pharmaceutical Co filed Critical Tobishi Pharmaceutical Co
Priority claimed from TH601004821A external-priority patent/TH87951A/en
Priority claimed from PCT/JP2006/320148 external-priority patent/WO2007037561A1/en
Publication of TW200801191A publication Critical patent/TW200801191A/en
Application granted granted Critical
Publication of TWI382090B publication Critical patent/TWI382090B/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides an activating agent of stem cell and/or progenitor cell comprising a thrombin-like enzyme which can be used in regenerative medicine, and particularly in regenerative medicine utilizing self-regeneration, acting promptly and moderately depending on the state of advancement and the degree of injured organs and/or tissues to which regenerative medicine is applied, with few or on side effects. The present invention also provides a method for activating stem cells and/or progenitor cells is an animal comprising the step of administering to the animal an effective amount of a thrombin-like enzyme and use of the thrombin-like enzyme for activating stem cell and/or progenitor cell.
TW095136179A 2005-09-30 2006-09-29 Activating agent of stem cells and/or progenitor cells TWI382090B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005288436 2005-09-30
TH601004821A TH87951A (en) 2006-09-29 Stem cell activating agent And / or cell projector
PCT/JP2006/320148 WO2007037561A1 (en) 2005-09-30 2006-10-02 Activating agent of stem cells and/or progenitor cells

Publications (2)

Publication Number Publication Date
TW200801191A true TW200801191A (en) 2008-01-01
TWI382090B TWI382090B (en) 2013-01-11

Family

ID=44764973

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095136179A TWI382090B (en) 2005-09-30 2006-09-29 Activating agent of stem cells and/or progenitor cells

Country Status (1)

Country Link
TW (1) TWI382090B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005090550A1 (en) * 2004-03-18 2005-09-29 Biomaster, Inc. Method of proliferating stem cell

Also Published As

Publication number Publication date
TWI382090B (en) 2013-01-11

Similar Documents

Publication Publication Date Title
BRPI0507812A (en) microactivation system, method for epidermal cell microactivation, kit, method for mounting the microactivation device and method for skin microactivation
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
AU2009240884A8 (en) Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
WO2007014323A3 (en) Use of heat shock to treat ocular disease
WO2008006895A3 (en) Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators
WO2006063072A3 (en) Immunomodulatory compositions, combinations and methods
AR069980A1 (en) IMMUNOCONJUGADOS DIRECTED AGAINST CD 138 AND ITS USES
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
MX2008001503A (en) Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin.
WO2008065660A3 (en) Oxygen supply for cell transplant and vascularization
EP2420568A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
WO2006074308A3 (en) Regeneration of pancreatic islets by amniotic fluid stem cell therapy
EP2070509A3 (en) The use of Myrica gale oil
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
EA200800722A1 (en) MEANS ACTIVATING STEM CELLS AND / OR PRECAUTIONAL CELLS
WO2011035018A3 (en) Suicide ready cells
WO2010019859A3 (en) Multiple cell therapeutic diffusion device
WO2008036421A3 (en) Reishi-mediated enhancement of human tissue progenitor cell adhesion and differentiation
IL200517A0 (en) Agent for use in the case of fructose intolerance
ATE549025T1 (en) ENAMEL FORMULATION WITH AMELOGENIN
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
WO2006113889A3 (en) Compositions and methods for modulating interleukin-10
AU2003215878A8 (en) Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
TW200801191A (en) Activating agent of stem cells and/or progenitor cells
WO2006069349A3 (en) Cell-loaded prostheses for regenerative intraluminal applications